Over the past 12 months, 4 insiders at Neurogene Inc. filed 16 open-market SEC Form 4 transactions on NGNE: 0 purchases worth $0 and 16 sales worth $978K. Insiders have been net sellers over this period. The most recent filing was on Jul 7, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | Christine Mikail CvijicPresident and CFO | SELL | 4.2K | $36.13 | $152K |
| Jul 6, 26 | Christine Mikail CvijicPresident and CFO | SELL | 600 | $36.02 | $22K |
| Jul 2, 26 | Christine Mikail CvijicPresident and CFO | SELL | 2.5K | $35.23 | $88K |
| Jul 1, 26 | Christine Mikail CvijicPresident and CFO | SELL | 739 | $34.06 | $25K |
| May 6, 26 | Christine Mikail CvijicPresident and CFO | SELL | 4.8K | $30.07 | $144K |
| Mar 26, 26 | Christine Mikail CvijicPresident and CFO | SELL | 2.6K | $21.62 | $55K |
| Mar 26, 26 | Julie JordanChief Medical Officer | SELL | 828 | $21.89 | $18K |
| Mar 26, 26 | Rachel McMinnChief Executive Officer | SELL | 3.4K | $22.07 | $74K |
| Mar 13, 26 | Stuart CobbChief Scientific Officer | SELL | 4.0K | $22.08 | $81K |
| Mar 13, 26 | Christine Mikail CvijicPresident and CFO | SELL | 2.4K | $22.02 | $49K |
| Feb 27, 26 | Christine Mikail CvijicPresident and CFO | SELL | 4.8K | $25.11 | $121K |
| May 14, 25 | Stuart CobbChief Scientific Officer | SELL | 6.8K | $15.15 | $103K |
| Mar 13, 25 | Christine Mikail CvijicPresident and CFO | SELL | 4.5K | $16.94 | $76K |
| Nov 26, 24 | Srinivas AkkarajuTenPercentOwner | BUY | 20.7K | $27.50 | $517K |
| Nov 22, 24 | Christine Mikail CvijicPresident and CFO | BUY | 24.0K | $20.48 | $492K |
| Nov 22, 24 | Rachel McMinnChief Executive Officer | BUY | 47.5K | $20.40 | $969K |
Over the past 12 months, insiders at Neurogene Inc. filed 0 open-market purchases worth $0 and 16 sales worth $978K on NGNE, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 7, 26.
The largest recent open-market NGNE insider purchase in our data was $969K by Rachel McMinn, Chief Executive Officer, filed on Nov 22, 24.
4 different insiders at Neurogene Inc. filed open-market SEC Form 4 transactions on NGNE over the last 12 months.
InsiderTape plots every NGNE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Neurogene Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →